T73_2	Disorder 1537 1553	MMR inactivation
T74_2	gene 1828 1831	MMR
T63_merge	size 1332 1338	eleven
T55_merge	size 1753 1757	1315
T49_merge	size 1470 1472	75
T29	disease 722 732	carcinomas
T28	cohort-patient 722 732	carcinomas
T27	gene 681 685	PMS2
T76_2	gene 320 323	MMR
T26	body-part 1758 1765	ovarian
T75_2	gene 1890 1893	MMR
T25	body-part 1617 1624	ovarian
T24	body-part 1576 1583	ovarian
T23	body-part 1473 1480	ovarian
T22	body-part 1094 1101	ovarian
T21	body-part 743 750	ovarian
T20	body-part 714 721	ovarian
T62	cohort-patient 1270 1280	responders
T64	cohort-patient 1339 1353	non-responders
T65	Disorder 1358 1376	not related to MSI
T30_merge	size 711 713	75
T79_2	gene 1403 1406	MMR
T59_merge	size 1248 1250	11
T77_2	gene 498 501	MMR
T38	Physiology 902 925	no MLH1 mRNA expression
T61_merge	size 1267 1269	34
T37	cohort-patient 895 900	SKOV3
T33	Disorder 779 782	MSI
T36	Physiology 841 892	no MLH1 mRNA expression due to promoter methylation
T35	cohort-patient 818 828	cell lines
T32	cohort-patient 758 768	cell lines
T60	cohort-patient 1251 1265	non-responders
T71_2	gene 1039 1042	MMR
T72_2	gene 1537 1540	MMR
T6	gene 660 664	MSH2
T70_2	gene 962 965	MMR
T7	gene 666 670	MSH3
T4	gene 905 909	MLH1
T5	gene 1120 1124	MLH1
T48	Physiology 1434 1453	No MMR inactivation
T8	gene 672 676	MSH6
T9	disease 98 112	ovarian cancer
T43	cohort-patient 1102 1112	carcinomas
T42	disease 1102 1112	carcinomas
T40	cohort-patient 1065 1075	cell lines
T46	Concepts_Ideas 1156 1180	none of these showed MSI
T45	disease 1863 1868	tumor
T44	Physiology 1120 1145	MLH1 promoter methylation
T31_merge	size 737 742	eight
T50	cohort-patient 1491 1500	specimens
T1	gene 546 550	MLH1
T3	gene 844 848	MLH1
T2	gene 654 658	MLH1
T39_merge	size 1059 1064	eight
T69_2	Physiology 1396 1419	not to MMR inactivation
T34_merge	size 799 817	three of the eight
T10	disease 153 167	ovarian cancer
T11	disease 341 355	ovarian cancer
T12	disease 743 757	ovarian cancer
T47_merge	size 1182 1191	Forty-six
T13	disease 1576 1590	ovarian cancer
T14	disease 1758 1772	ovarian cancer
T15	cohort-patient 1201 1209	patients
T52	disease 1625 1635	carcinomas
T16	cohort-patient 1773 1781	patients
T51	disease 1481 1490	carcinoma
T80_2	gene 1437 1440	MMR
T17	body-part 98 105	ovarian
T54	cohort-patient 1591 1601	cell lines
T18	body-part 153 160	ovarian
T19	body-part 341 348	ovarian
T56	cohort-patient 834 839	A2780
T41_merge	size 1078 1093	Seven of the 75
T58	Physiology 937 971	no altered expression of MMR genes
T57	cohort-patient 931 935	2774
R16_m	has Arg1:T44 Arg2:T42
R9_m	has Arg1:T32 Arg2:T31_merge
R34_2	has Arg1:T33 Arg2:T35
R33_m	has Arg1:T46 Arg2:T42
R24_m	relatedTo Arg1:T26 Arg2:T14
R35_2	has Arg1:T65 Arg2:T64
R26_m	has Arg1:T16 Arg2:T55_merge
R29_m	has Arg1:T60 Arg2:T59_merge
R15_m	has Arg1:T43 Arg2:T42
R27_m	has Arg1:T40 Arg2:T39_merge
R0_T48_T80_2	has Arg1:T48 Arg2:T80_2
R25_m	has Arg1:T16 Arg2:T14
R8_m	has Arg1:T32 Arg2:T12
R20_m	has Arg1:T50 Arg2:T51
R0_T38_T4	has Arg1:T38 Arg2:T4
R7_m	relatedTo Arg1:T21 Arg2:T12
R21_2	has Arg1:T48 Arg2:T50
R4_m	relatedTo Arg1:T20 Arg2:T29
R18_m	has Arg1:T50 Arg2:T49_merge
R18_1	has Arg1:T48 Arg2:T51
R30_m	has Arg1:T62 Arg2:T61_merge
R12_2	has Arg1:T58 Arg2:T57
R0_T69_2_T79_2	has Arg1:T69_2 Arg2:T79_2
R19_m	relatedTo Arg1:T23 Arg2:T51
R13_m	has Arg1:T43 Arg2:T41_merge
R0_T58_T70_2	has Arg1:T58 Arg2:T70_2
R28_m	has Arg1:T64 Arg2:T63_merge
R3_m	relatedTo Arg1:T19 Arg2:T11
R10_m	has Arg1:T35 Arg2:T34_merge
R0_T44_T5	has Arg1:T44 Arg2:T5
R2_m	relatedTo Arg1:T18 Arg2:T10
R32_2	has Arg1:T38 Arg2:T37
R5_m	has Arg1:T28 Arg2:T30_merge
R6_m	has Arg1:T28 Arg2:T29
R11_2	has Arg1:T36 Arg2:T56
R31_m	has Arg1:T54 Arg2:T13
R17_m	has Arg1:T15 Arg2:T47_merge
R0_T73_2_T72_2	has Arg1:T73_2 Arg2:T72_2
R23_m	relatedTo Arg1:T25 Arg2:T52
R0_T36_T3	has Arg1:T36 Arg2:T3
R1_m	relatedTo Arg1:T17 Arg2:T9
R14_m	relatedTo Arg1:T22 Arg2:T42
R22_m	relatedTo Arg1:T24 Arg2:T13
